| 12466831 |
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use |
Zachary G. Brill, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +7 more |
2025-11-11 |
|
| 12263171 |
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use |
Yonglian Zhang, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +10 more |
2025-04-01 |
|
| 12060357 |
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use |
Matthew A. Larsen, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +11 more |
2024-08-13 |
$234,312,000 |
| 11312719 |
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use |
Matthew A. Larsen, Amjad Ali, Jared N. Cumming, Duane DeMong, Qiaolin Deng +11 more |
2022-04-26 |
$216,387,000 |
| 11230543 |
Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections |
Haifeng Tang, Weiguo Liu, Fa-Xiang Ding, Wanying Sun, Yi Zang +11 more |
2022-01-25 |
$195,577,000 |
| 11161819 |
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists |
Gregory L. Adams, Jason M. Cox, John S. Debenham, Scott D. Edmondson, Eric J. Gilbert +15 more |
2021-11-02 |
$152,718,000 |
| 10968193 |
Antidiabetic bicyclic compounds |
Helen Chen, Steven L. Colletti, Duane DeMong, Yan Guo, Michael Miller +3 more |
2021-04-06 |
$229,405,000 |
| 10662171 |
Antidiabetic bicyclic compounds |
Harry R. Chobanian, Duane DeMong, Yan Guo, Barbara Pio |
2020-05-26 |
$186,154,000 |
| 10131651 |
[7,6]-fused bicyclic antidiabetic compounds |
Harry R. Chobanian, Duane DeMong, Minghai Fang, Bin Hu |
2018-11-20 |
$74,257,000 |
| 10100042 |
[5,6]—fused bicyclic antidiabetic compounds |
Helen Chen, Duane DeMong, Paul E. Finke |
2018-10-16 |
$100,852,000 |
| 10059667 |
Antidiabetic compounds |
Harry R. Chobanian, Duane DeMong, Yan Guo, Zhiyong Hu, Michael Miller +3 more |
2018-08-28 |
$100,134,000 |
| 10000454 |
Antidiabetic tricyclic compounds |
Tesfaye Biftu, Purakkattle Biju, Timothy A. Blizzard, Zhengxia Chen, Matthew J. Clements +7 more |
2018-06-19 |
$67,511,000 |
| 9957219 |
Antidiabetic bicyclic compounds |
Thomas Bara, Harry R. Chobanian, Yan Guo, Hubert Josien, Michael Miller +3 more |
2018-05-01 |
$129,774,000 |
| 9840512 |
Antidiabetic bicyclic compounds |
Linda Brockunier, Helen Chen, Harry R. Chobanian, Matthew J. Clements, Alejandro Crespo +7 more |
2017-12-12 |
$85,898,000 |
| 9527875 |
Antidiabetic tricyclic compounds |
William K. Hagmann, Ravi Nargund, Timothy A. Blizzard, Hubert Josien, Purakkattle Biju +8 more |
2016-12-27 |
$78,520,000 |
| 7572785 |
Substituted imidazoles as cannabinoid receptor modulators |
Paul E. Finke, Sander G. Mills, Shrenik K. Shah, Quang T. Truong |
2009-08-11 |
$112,059,000 |
| 7091211 |
Cyclopentyl modulators of chemokine receptor activity |
Paul E. Finke, Jennifer L. Loebach, Kerry Parker, Sander G. Mills |
2006-08-15 |
$42,201,000 |
| 7057051 |
Substituted imidazoles as cannabinoid receptor modulators |
Paul E. Finke, Sander G. Mills, Shrenik K. Shah, Quang T. Truong |
2006-06-06 |
$96,639,000 |
